HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tria Launches Home-Use Laser For Skin Rejuvenation In U.K.

This article was originally published in The Rose Sheet

Executive Summary

Tria Beauty’s Skin Rejuvenating Laser launches to U.K. consumers through the firm’s website and Selfridges department stores. The device offers a more convenient and economical alternative to professional laser therapy or a means of extending the benefit of in-office treatments, the company says.

You may also be interested in...



Topicals In Trouble? TRIA Skin Rejuvenating Laser To Launch OUS

TRIA Beauty seeks “growth, growth and more growth” as it prepares to launch its anti-aging laser for home use in markets outside of the U.S. If the firm delivers on its efficacy claims, President and CEO Kevin Appelbaum expects users to reevaluate their topical product use, as some elements of their regimens may no longer be necessary.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts

Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018264

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel